Which modality for prostate brachytherapy?;Quelle modalité de curiethérapie prostatique ?

Cancer/Radiotherapie

Volumn 14, Issue 6-7, 2010, Pages 488-492

  Bossi, A ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Focal therapy for prostate cancer; High dose rate brachytherapy; Intermediate and high risk prostate cancer; Low risk prostate cancer; Permanent implant brachytherapy

Indexed keywords

RADIOACTIVE IODINE; DRUG IMPLANT;

BRACHYTHERAPY; CANCER CONTROL; CANCER RELAPSE; CANCER RISK; CLINICAL PROTOCOL; CRYOTHERAPY; DOSIMETRY; DRUG DOSE ESCALATION; DRUG IMPLANT; EXTERNAL BEAM RADIOTHERAPY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MINIMALLY INVASIVE PROCEDURE; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; PROSTATECTOMY; RADIATION DOSE FRACTIONATION; RETREATMENT; SALVAGE THERAPY; SHORT SURVEY; TREATMENT INDICATION; ADENOCARCINOMA; CLINICAL TRIAL (TOPIC); FOLLOW UP; MALE; MULTICENTER STUDY (TOPIC); NEOPLASM RECURRENCE, LOCAL; PROCEDURES; PROSTATIC NEOPLASMS; RADIATION DOSE; RISK; TREATMENT OUTCOME;

ADENOCARCINOMA; BRACHYTHERAPY; CLINICAL TRIALS AS TOPIC; DOSE FRACTIONATION; DRUG IMPLANTS; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MULTICENTER STUDIES AS TOPIC; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RISK; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 77957258394     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.06.009     Document Type: Short Survey

References (31)

1. Allen G.W., Howard A.R., Jarrad D.E., Ritter M.A. Management of prostate cancer recurrences after radiation therapy - brachytherapy as a salvage option. Cancer 2007, 110:1405-1416.
2. Astrom L., Pedersen D., Mercke C., Holmang S., Johansson K.A. Long-term outcome of high-dose-rate brachytherapy in radiotherapy of localized prostate cancer. Radiother Oncol 2005, 74:157-161.
3. Beyer D.C. Brachytherapy for recurrent prostate cancer after radiation therapy. Semin Radiat Oncol 2003, 13:158-165.
4. Bostwick D.G., Waters D.J., Fatley E.R. Group consensus reports from the consensus conference on focal treatments of prostatic carcinoma. Urology 2007, 70(suppl. 6):42-44.
5. Burri R.J., Stone N.N., Unger P., Stock R.G. Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010, 77(5):1338-1344.
6. Cosset J.M., Flam T., Thiounn, Pontvert D., Pierrat N., Vallancien G., et al. La curiethérapie du cancer prostatique par implants permanents. Cancer Radiother 2008, 12:503-511.
7. Cosset J.M., Flam T., Thiounn N., Rosenwald J.C., Pontvert D., Timbert M., et al. La curiethérapie du cancer prostatique: une idée ancienne, des techniques nouvelles. Bull Cancer 2006, 93:761-766.
8. Cosset J.M., Haie-Meder C. Curiethérapie du cancer prostatique: haut débit ou bas débit de dose ?. Cancer Radiother 2005, 9:610-619.
9. Eggener S.E., Scardino P.T., Carroll P.R. International Task Force on prostate cancer and the focal lesion paradigm: focal therapy for localised prostate cancer. A critical appraisal for rationale and modalities. J Urol 2007, 178:2260-2267.
10. Ghilezan M., Park S., Ye H., Gustafson G., Brabbins D., Chen P., et al. A modified Phoenix biochemical failure (BF) definition to account for PSA bounce phenomenon for prostate cancer patients treated with brachytherapy (BT). Int J Radiat Oncol Biol Phys 2009, 75:S311. [abstract 2288].
11. Hennequin C. Oncoforum en urologie et revue de la littérature. Cancer Radiother 2008, 12:1-8.
12. Hoskin P. High-dose-rate brachytherapy for prostate cancer. Cancer Radiother 2008, 12:512-514.
13. Hoskin P., Motobashi K., Bownes P., Bryant L., Ostler P. High-dose-rate brachytherapy in combination with external beam readiotherapy in the radical treatment of prostate cancer: initial results of a randomized phase three trial. Radiother Oncol 2007, 84:114-120.
14. Hsu I.C., Bae K., Shinoara K., Pouliot J., Purdy J., Ibbott G., et al. Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG0321. Int J Radiat Oncol Biol Phys 2010, http://dx.doi.org/10.1016/j.ijrobp.2009.08.048.
15. Jani A.B., Feinstein J.M., Pasciak R., Krengel S., Weichselbaum R.R. Role of external beam radiotherapy with low-dose-rate brachytherapy in treatment of prostate cancer. Urology 2006, 67:1007-1011.
16. Kovacs G., Potter R., Loch T., Hammer J., Kolkman-Deurloo I.-K., de la Rosette JJMCH, et al. GEC-ESTRO-EAU recommandations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiother Oncol 2005, 74:137-148.
17. Lawton C.A., Hunt D., Lee W.R., Gomella L., Grignon D., Gillin M., et al. Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05). Int J Radiat Oncol Biol Phys 2009, 75:S12. [abstract 25].
18. Lee W.R., Bae K., Lawton C.A. Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019. Cancer 2007, 109:1506-1512.
19. Mallet F., Wdowczyk D., Bruna A., Villena P., Herard A., Amory J.P., et al. Faisabilité et toxicité d'une séance unique de curiethérapie de haut débit de dose suivi d'une irradiation externe dans le cancer localisé de la prostate: étude rétrospective de la polyclinique de Courlancy. Cancer Radiother 2010, 14:11-18.
20. Martinez A.A., Demanes J., Vargas C., Schour L., Ghilezan M., Gustafson G.S. High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer. Am J Clin Oncol 2009, http//:dx.doi.org/10.1097/COC.0b013e3181b9cd2f.
21. Morton G.C., Loblaw D.A., Sankreacha R., Deabreu A., Zhang L., Mamedov A., et al. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life. Int J Radiat Oncol Biol Phys 2010, 77(3):811-817.
22. Peiffert D. Curiethérapie interstitielle des cancers localisé de prostate par implants permanents d'iode-125. Cancer Radiother 2005, 9:388-393.
23. Pieters B.R., de Back D.Z., Koning C.C.E., Zwinderman A.H. Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review. Radiother Oncol 2009, 93:168-173.
24. Pieters B.R., van der Kamer J.B., van Herten H.R.J. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy. Radiother Oncol 2008, 88:46-52.
25. Pistis F., Guedea F., Pera J., Gutierrez C., Ventura M., Polo A., et al. External beam radiotherapy plus high-dose-rate brachytherapy for treatment of locally advanced prostate cancer: the initial experience of the Catalan Institute of Oncology. Brachytherapy 2010, 9:15-22.
26. Recommandations 2007 en uro-oncologie. Prog Urol 2007, 17:1017-1059. AFU, SFRO, Gétug, SFP.
27. Salembier C., Lavagnini P., Nickers P., Mangili P., Rjinders A., Polo A., et al. Tumor and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. Radiother Oncol 2007, 83:3-10.
28. Shah J.N., Wuu C.S., Katz A.E., Laguna J.L., Benson M.C., Ennis R.D. Improved biochemical control and disease free survival with intraoperative versus preoperative preplanning for transperineal interstitial permanent prostate brachytherapy. Cancer 2006, 12:289-297.
29. Sylvester J.E., Grimm P.D., Blasko C. 15-year biochemical relapse free survival in clinical stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy: Seattle experience. Int J Radiat Oncol Biol Phys 2007, 67:57-64.
30. Tharp M., Hardacre M., Bennett R., Jones W.T., Stuhldreher D., Vaught J. Prostate high dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer. Brachytherapy 2008, 7:231-236.
31. Vargas C.E., Martinez A.A., Boike T.P. High-dose irradiation of prostate cancer via a high-dose-rate brachytherapy boost: results of a phase I to II study. Int J Radiat Oncol Biol Phys 2006, 66:416-423.